132 related articles for article (PubMed ID: 34423963)
1. Polymeric Composite Matrix with High Biobased Content as Pharmaceutically Relevant Molecular Encapsulation and Release Platform.
Hazra RS; Dutta D; Mamnoon B; Nair G; Knight A; Mallik S; Ganai S; Reindl K; Jiang L; Quadir M
ACS Appl Mater Interfaces; 2021 Sep; 13(34):40229-40248. PubMed ID: 34423963
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of Cellulose-Nanocrystal-Based Folate Targeted Nanomedicine via Layer-by-Layer Assembly with Lysosomal pH-Controlled Drug Release into the Nucleus.
Li N; Zhang H; Xiao Y; Huang Y; Xu M; You D; Lu W; Yu J
Biomacromolecules; 2019 Feb; 20(2):937-948. PubMed ID: 30621397
[TBL] [Abstract][Full Text] [Related]
3. Injectable Biocompatible Hydrogels from Cellulose Nanocrystals for Locally Targeted Sustained Drug Release.
Bertsch P; Schneider L; Bovone G; Tibbitt MW; Fischer P; Gstöhl S
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38578-38585. PubMed ID: 31573787
[TBL] [Abstract][Full Text] [Related]
4. Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.
Mamnoon B; Loganathan J; Confeld MI; De Fonseka N; Feng L; Froberg J; Choi Y; Tuvin DM; Sathish V; Mallik S
ACS Appl Bio Mater; 2021 Feb; 4(2):1450-1460. PubMed ID: 33954285
[TBL] [Abstract][Full Text] [Related]
5. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
Nittayacharn P; Nasongkla N
J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of doxorubicin from polyethylene glycol functionalized melanin nanoparticles for breast cancer therapy: Part I. Production and drug release performance of the melanin nanoparticles.
Ozlu B; Kabay G; Bocek I; Yilmaz M; Piskin AK; Shim BS; Mutlu M
Int J Pharm; 2019 Oct; 570():118613. PubMed ID: 31415880
[TBL] [Abstract][Full Text] [Related]
9. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
Yu Y; Chen CK; Law WC; Weinheimer E; Sengupta S; Prasad PN; Cheng C
Biomacromolecules; 2014 Feb; 15(2):524-32. PubMed ID: 24446700
[TBL] [Abstract][Full Text] [Related]
10. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
11. Chitosan nanoparticles/cellulose nanocrystals nanocomposites as a carrier system for the controlled release of repaglinide.
Abo-Elseoud WS; Hassan ML; Sabaa MW; Basha M; Hassan EA; Fadel SM
Int J Biol Macromol; 2018 May; 111():604-613. PubMed ID: 29325745
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of magnetic NaX zeolite/DOX into the PLA/chitosan nanofibers for sustained release of doxorubicin against carcinoma cells death in vitro.
Abasian P; Radmansouri M; Habibi Jouybari M; Ghasemi MV; Mohammadi A; Irani M; Jazi FS
Int J Biol Macromol; 2019 Jan; 121():398-406. PubMed ID: 30287373
[TBL] [Abstract][Full Text] [Related]
13. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
14. Rod-like cellulose nanocrystal/cis-aconityl-doxorubicin prodrug: A fluorescence-visible drug delivery system with enhanced cellular uptake and intracellular drug controlled release.
Li N; Lu W; Yu J; Xiao Y; Liu S; Gan L; Huang J
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():179-189. PubMed ID: 30033244
[TBL] [Abstract][Full Text] [Related]
15. Dual-purpose Injectable Doxorubicin Conjugated Alginate Gel Containing Polycaprolactone Microparticles for Anti-Cancer and Anti-Inflammatory Therapy.
Pawar V; Borse V; Thakkar R; Srivastava R
Curr Drug Deliv; 2018; 15(5):716-726. PubMed ID: 29034837
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
18. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous controlled release of 5-FU, DOX and PTX from chitosan/PLA/5-FU/g-C3N4-DOX/g-C3N4-PTX triaxial nanofibers for breast cancer treatment in vitro.
Habibi Jouybari M; Hosseini S; Mahboobnia K; Boloursaz LA; Moradi M; Irani M
Colloids Surf B Biointerfaces; 2019 Jul; 179():495-504. PubMed ID: 31005745
[TBL] [Abstract][Full Text] [Related]
20. Polyphosphoester-based nanoparticles with viscous flow core enhanced therapeutic efficacy by improved intracellular drug release.
Ma YC; Wang JX; Tao W; Qian HS; Yang XZ
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16174-81. PubMed ID: 25188541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]